We are live on ! Find out more
PROK icon

ProKidney
PROK

35 hedge funds and large institutions have $391M invested in ProKidney in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

81% more capital invested

Capital invested by funds: $216M → $391M (+$176M)

30% more funds holding

Funds holding: 27 → 35 (+8)

5.09% more ownership

Funds ownership: 51.08% → 56.17% (+5.1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
35
Holders Change
+8
Holders Change %
+29.63%
% of All Funds
0.56%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
16
Reduced
5
Closed
1
Calls
$131K
Puts
–
Net Calls
+$131K
Net Calls Change
+$131K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$42.3M
2
Millennium Management
Millennium Management
New York
+$1.09M
3
BlackRock
BlackRock
New York
+$1.09M
4
Bank of America
Bank of America
North Carolina
+$729K
5
HF
HRT Financial
New York
+$687K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$14.2M
2
Swiss National Bank
Swiss National Bank
Switzerland
-$84.1K
3
CLOS
Compagnie Lombard Odier SCmA
Switzerland
-$72K
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$33.2K
5
US Bancorp
US Bancorp
Minnesota
-$6.29K

PROK Hedge Fund Activity: Q1 2023 in Review

35 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q1 2023, worth a combined $391M — up 81% from $216M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PROK positions and 1 closed out — a net gain of 8 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $42.3M. The largest seller was Morgan Stanley, cutting an estimated $14.2M.

  • 35 institutional investors held ProKidney (PROK) as of Q1 2023, up from 27 in Q4 2022.
  • Funds reported $391M of ProKidney stock for Q1 2023, up 81% quarter-over-quarter.
  • 9 funds opened new ProKidney positions in Q1 2023 and 1 closed out, a net change of +8 holders.
  • The largest ProKidney buyer in Q1 2023 was Vanguard Group, an estimated $42.3M added.
  • The largest ProKidney seller in Q1 2023 was Morgan Stanley, an estimated $14.2M sold.

Based on aggregated 13F filings for Q1 2023.